Back to search

Article

Proteogenomic Metabolism Dependent Signature Identifies Worse Outcome in Breast And Other Cancers

2022-03-17

Abstract excerpt

<title>Abstract</title> <p>Breast cancer (BrCA) therapeutic selection routinely incorporates clinicopathologic information along with immunohistochemistry (IHC) for ER/PR/HER2/Ki-67. However, this is incomplete and has shortcomings that are seen in clinical outcome differences even within the same subtype. Herein, we analyzed the proteome of 116 HER2-negative primary BrCA samples and subsequently validated a 34-p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c718dd47-e20c-56e8-a9b2-4569f87917fa
DOI
10.21203/rs.3.rs-1443160/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Proteogenomic Metabolism Dependent Signature Identifies Worse Outcome in Breast And Other CancersDOI 10.21203/rs.3.rs-1443160/v1
Correlation between metabolic characteristics and breast cancer subtypes and prognosisSemantic proximity
Clinical proteomics reveals vulnerabilities in non-invasive breast ductal carcinoma and drives personalized treatment strategiesSemantic proximity
Multi-Omics and Single-Cell Sequencing Reveal the Genomic Features and Metabolic Heterogeneity of Low Ki-67 Triple-Negative Breast CancerSemantic proximity
Single-cell sequencing and transcriptome analysis identified a comprehensive risk score model based on immune-related metabolic genes for improving the prediction of sensitivity in breast cancer immunotherapySemantic proximity
Immunometabolism characteristics and a potential prognostic risk model associated with TP53 mutations in breast cancer.Semantic proximity
Integrative Transcriptomic Analysis Identifies ADIPOQ, LIPE, LEP, SLC2A4, and LPL as Prognostic Metabolic Markers in Breast CancerSemantic proximity
Development and Validation of a Prognostic Classifier Based on Metabolism-Related Genes for Breast CancerSemantic proximity
Breast cancer metabolic subtypes analysis and risk prognostic models construction based on glycolysis metabolism genesSemantic proximity
A joint analysis of metabolomics and genetics of breast cancer.Semantic proximity
Integrated Metabolic and Gene Expression Profiling Reveals New Therapeutic Modalities for Rapidly Proliferating Breast CancersSemantic proximity
Comprehensive Analysis of Mitochondrial Metabolism Related Molecular Subtypes and Prognostic Scoring Model Index Construction in Breast CancerSemantic proximity
WITHDRAWN: Establishment and validation of a novel metabolism-related genesignature for predicting overall survival of patients with breast cancerSemantic proximity
Select a neighboring publication to make it the new centre.